Abstract
Background Contact tracing is a key part of the public health surveillance toolkit. However, it is labor intensive and costly to carry it out. Some countries have faced challenges implementing contact tracing, and no impact evaluations to our knowledge have assessed its impact on COVID-19 mortality. This study assesses the impact of contact tracing in a middle-income country and provides data to support the expansion of contact tracing strategies with the aim of improving infection control.
Methods We obtained publicly available data on all confirmed COVID-19 cases in Colombia between March 2 and June 16, 2020. (N=54,931 cases over 135 days of observation). We proxied contact tracing performance as the proportion of cases identified through contact tracing out of all cases identified, as suggested by WHO guidelines. We calculated the daily proportion of cases identified through contact tracing across 37 geographical units (32 departments and five districts). Further, we used a sequential log-log fixed-effects model to estimate the 21-days, 28-days, 42-days and 56-days lagged impact of the proportion of cases identified through contact tracing on the daily number of COVID-19 deaths. Both the proportion of cases identified through contact tracing and the daily number of COVID-19 deaths are smoothed using 7-day moving averages. Models control for prevalence of active cases, second-degree polynomials, and mobility indices. Robustness checks to include supply-side variables were performed.
Results We found that a 10 percent increase in the proportion of cases identified through contact tracing is related to COVID-19 mortality reductions between 0.8% and 3.4%. Our models explain between 47%-70% of the variance in mortality. Results are robust to changes of specification and inclusion of supply-side variables.
Conclusion Contact tracing is instrumental to contain infectious diseases and its prioritization as a surveillance strategy will have a substantial impact on reducing deaths while minimizing the impact on the fragile economic systems of lower and middle-income countries. This study provides lessons for other LMIC.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was obtained for this research
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A. This is publicly available anonymized data
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
julianavillanueva{at}javeriana.edu.co
solsilvana{at}yahoo.com
zulma.cucunuba{at}imperial.ac.uk
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
2
Blogs/Media
Author Videos